Free tool
Diagnostics stocks
We cover 12 companies grouped under the Diagnostics theme. The median market value in the group is $54.87M. Across the group, the median move over the past trading day is +0.16%. Price change over the past year runs from −40.4% to +106.5% across the middle 80 percent of the group, with a median of +22.1%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
12 of 150 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| NTRA | Natera, Inc. | $336.71 | +30.49% | +47.14% | +107.24% |
| 0KSX.L | Quest Diagnostics Incorporated | $243.72 | +0.48% | +42.44% | +36.94% |
| LH | Labcorp Holdings Inc. | $337.68 | +12.12% | +34.52% | +23.25% |
| 0JSY.L | Labcorp Holdings Inc. | $334.61 | +1.86% | +33.14% | +20.97% |
| DGX | Quest Diagnostics Incorporated | $244.51 | +5.46% | +41.95% | +38.70% |
| PRPO | Precipio, Inc. | $30.85 | +34.60% | +29.51% | +117.41% |
| RIBB | Ribbon Acquisition Corp. | $10.88 | +0.51% | +4.97% | +6.62% |
| ABDX.L | Abingdon Health Plc | 11.00 GBP | +11.68% | +71.87% | +100.00% |
| RENX.L | Renalytix Plc | 4.25 GBP | +60.38% | −27.97% | −27.35% |
| GSS.AX | Genetic Signatures Limited | 0.08 AUD | +38.33% | −66.12% | −72.33% |
| CNSL.L | Cambridge Nutritional Sciences plc | 1.90 GBP | +8.57% | −2.56% | −41.54% |
| BIAF | bioAffinity Technologies, Inc. | $5.19 | +661.00% | +325.41% | −30.52% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.